#1985 Alpha Score 5.7

Ha In-hwan

Analyst
· tracked since Aug 2026
1985
BUZZBERG The leaderboard is ranked by Alpha Score, which weighs a speaker's average return and number of evaluated calls. Small samples are adjusted toward the platform average. Credibility does not affect the score. Read the FAQ
Alpha Score 5.7
Calls
9
Win Rate
11.1%
return
-12.8%
Calls 9 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 9
Win Rate 11% Long 9 Short 0
Win Rate
7d 56%
30d 11%
90d —
Average Return -12.8% Long Return -12.8% Short Return -
Average Return
7d +1.5%
30d -16.3%
90d —
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
347850.KQ 1ST D&D Phar... D&D Pharmatech Inc.
Long
Aug 04
$64300.00
-29.5%
Biopharma shows momentum from obesity drugs, CDMO.
Biopharma stocks are showing strong momentum from obesity drugs and CDMO commercialization news.
GLP-1 / Obesity
YOUTUBE
226950.KQ 1ST OliX Pha... OliX Pharmaceuticals, Inc.
Long
Aug 04
$121600.00
-8.2%
Biopharma shows momentum from obesity drugs, CDMO.
Biopharma stocks are showing strong momentum from obesity drugs and CDMO commercialization news.
Pharma & Biotech
YOUTUBE
087010.KQ 1ST Peptron, Inc. Peptron, Inc.
Long
Aug 04
$180400.00
-13.5%
Biopharma shows momentum from obesity drugs, CDMO.
Biopharma stocks are showing strong momentum from obesity drugs and CDMO commercialization news.
GLP-1 / Obesity
YOUTUBE
Showing 3 of 9 calls · sorted by mentions

Ha In-hwan has 9 trade ideas tracked on Buzzberg across 9 tickers since August 2026. Ranked #1985 on the Buzzberg Alpha leaderboard. Most covered: 010060.KS, 226950.KQ, 347850.KQ.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology